Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Preliminary trial supports use of dextroamphetamine for methamphetamine addiction

Jan. 28, 2010

Cleveland BioLabs initiates dosing in phase Ib trial of CBLB-502

Jan. 21, 2010

Aeolus invited to submit full proposal to BARDA for further development AEOL-10150

Jan. 18, 2010

Kappa-opioid receptor antagonists claimed by Janssen for treatment of addiction

Dec. 29, 2009

Cleveland BioLabs initiates enrollment in safety study of CBLB-502 for ARS

Nov. 27, 2009

Alkermes initiates phase II trial of ALKS-33 for alcohol dependence

Nov. 19, 2009

Naltrexone implant shown to be safe and effective in heroin dependence

Nov. 18, 2009

GSK and Nabi sign option and licensing agreement for NicVAX nicotine vaccine

Nov. 17, 2009

Alkermes reports results from phase III naltrexone trial for opioid dependence

Nov. 17, 2009

Results reported for phase I clinical trial of new slow-release metadoxine

Nov. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...